Jump to content
PathLabTalk

Joanne P. Scannell

Members
  • Content Count

    255
  • Joined

  • Last visited

  • Days Won

    15
  • Country

    United States

Joanne P. Scannell last won the day on September 13

Joanne P. Scannell had the most liked content!

About Joanne P. Scannell

  • Rank
    Senior Member
  • Birthday 10/10/1952

Profile Information

  • Gender
    Female
  • Location
    Massachusetts
  • Occupation
    Blood Bank Manager

Recent Profile Visitors

The recent visitors block is disabled and is not being shown to other users.

  1. There are actually 2 scenarios in this string: 1. Issuing plasma that you know is incompatible with a patient (i.e. ABO is verified) and 2. Issuing plasma when you haven't verified the patient's ABO with a current sample. For #1: If you are in the US, the CDC/FDA wants us to treat all incompatible plasma as if it were 'Emergency Release' so use your Emergency Release Protocol. For #2: If your patient's ABO Group has not been verified (e.g. sample tested using your protocol for verification), use your Emergency Release Protocol.
  2. We have found that washing the cells 3x with 37C saline will resolve this situation in just about every case where RT Saline wash doesn't help. If you are using Gel, there may be other reasons for the extraneous 'positive results' using your patient cells, e.g. sickled cells, acanthrocytes, protein coating. So, those must also be considered.
  3. We validated using Anti-C3 in a Neutral Gel card.
  4. Yes on every question except the 2u limit. If we have verified the ABO Group and we need to use 'incompatible' plasma (i.e. emergency), we use our Emergency Release Protocol, e.g. MD signs for it. If you want to view our policy, please message me.
  5. I hear there is some chatter/literature about immunizing Rh-Neg Females under 50 is, today, probably 'much ado about nothing'. Well, not nothing, but the argument is, with today's techniques (in utero transfusions, more sensitive monitoring, etc.), the risk of HDN is less likely than it was 'all those years ago'. Does anyone have any articles or insight about this 'new turn' to share?
  6. We switched to Rhophylac here in the hospital because 'everyone' likes having the option of giving the dose IM or IV. The MD's are still using RhoGam (no IV option) for their office injections (IM Only), e.g. Antenatal/Antepartum dose.
  7. Without some sort of 'vending machine' device to control and document the in/out/in/out/transfused to whom information, just leaving O Neg RBCs in a refrigerator somewhere for nursing to take/return at will is not a good idea. I'm not even sure if regulatory agencies will support that. Not only that, giving O Neg to 'everyone' is not good management of resources. We (and most hospitals in our area at) restrict the use of O Neg to Females <50yrs old. (And even that is coming up for debate in some arenas.) There are 'vending machines' out there that will interface with some Blood
  8. As you see from the posts here, there are various opinions of what to do. Correct =The regulatory agencies do state to run some sort of controls, etc. You are in charge, therefore you do what you believe is best within the guidelines when there are gray areas like this. If you believe you should change the protocol to 'QC for the Antigen', then do that. Validation? You have criteria, I'm sure, for the cells passing inspection for use. I venture to say that most hospitals don't keep reagent RBCs more than a month or two past their outdate. It would be interesting to hear ab
  9. 'Liquid Plasma' is never frozen so there's no need to thaw it therefore the outdate is not changed. 'Thawed Plasma' is the 5 Day product which results from Thawing Frozen Plasma (in all it's various forms, FFP, FP24, etc.). Note: When Frozen Plasma is thawed, it is assigned a 24hr outdate. You can extend that outdate to 5 Days IF you label it 'Thawed Plasma'. e.g. Frozen FFP is thawed to Fresh Frozen Plasma (24h outdate). You can leave it that way or change it to 'Thawed Plasma' (no FFP designation) and assign a 5 Day outdate to it. Most hospitals, if they go that route, just
  10. I think that is the point = remove the requirement for the hospitals to perform the Retyping. Motivation? I agree that it is a waste of time and resources. The labeling facility has already tested the unit and rechecked it how many times? How many discrepancies have you found in your career? In over 40 years of mine, I have never seen a discrepancy. That's not of the units I have personally rechecked, it's of the 100s of thousands of units I have overseen. And, please correct me if I'm wrong, I don't think they do this recheck in the hospitals in the UK, maybe all of Europe? H
  11. Good point ... but most MDs give the RhIg when Weak/Partial D is reported because they don't understand the situation even if we try to explain it to them.
  12. We use gel, and as other are doing, if Rh Neg with Gel, we test for Weak D. I must add this caution: Be mindful of what your Anti-D is capable of detecting. Some purposely do not detect DVI. You want to detect DVI on these newborns to determine the possibly of immunizing an Rh-Neg mother, i.e. Is she a candidate for Rh-Immune Globulin. n.b. Currently, we are using an Anti-D reagent that detects DVI (as well as other Weak D) at Immediate Spin, so the 'Weak D typing' is very quick and simple.
  13. We keep them for a month or two. Once I do my 'turn around, vendor assessment audit', I toss them. Why? 1. These aren't handwritten papers anymore, we have other records bearing the exact same data generated by the exact same actions: All units scanned as shipped appear on the 'packing slip' and on our account, i.e. A unit is not going to be listed on a packing slip that does not appear on our account and vice versa. 2. The techs correlate the packing slip with the actual units at the time of receipt so we know the numbers are right. Discrepancies are remedied at that time.
  14. We give units tested for HgbS Neg only if they are for RBC Exchange Transfusions.
×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.